Details for 2013792152
Up to date per 09.04.2026
Actions
Details for 2013792152
Deleted
European Patent
09.09.2015 A
06.03.2019 B1
02.11.2012
IN
CH45952012
02.03.2013
US
201361771812 P
A61P 35/00 20060101AFI20140522BHEP
Owner
TG Therapeutics, Inc.2 Gansevoort St., 9th Floor New York, NY 10014US
Rhizen Pharmaceuticals S.A.Fritz Courvoisier 40 2300 La Chaux de FondsCH
Laboratoire Français du Fractionnement et des Biotechnologies3, Avenue des Tropiques ZA de Courtaboeuf 91940 Les UlisFR
Representative
No representatives present
Inventor
WEISS, Michaelc/o TG Therapeutics, Inc. 2 Gansevoort St. 9th Floor New York, NY 10014US
MISKIN, Haric/o TG Therapeutics Inc. 2 Gansevoort St. 9th Floor New York New York 10014US
SPORTELLI, Peterc/o TG Therapeutics, Inc. 2 Gansevoort St. 9th Floor New York New York 10014US
VAKKALANKA, Swaroop K.V.S.c/o Rhizen Pharmaceuticals SA Fritz Courvoisier 40 2300 La Chaux de FondsCH